Norbert Galldiks
Norbert Galldiks
Professor of Neurology, University Hospital Cologne & Research Center Juelich (INM-3)
Dirección de correo verificada de
Citado por
Citado por
Role for neuronal insulin resistance in neurodegenerative diseases
M Schubert, D Gautam, D Surjo, K Ueki, S Baudler, D Schubert, T Kondo, ...
Proceedings of the National Academy of Sciences 101 (9), 3100-3105, 2004
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ...
Neuro-oncology 18 (9), 1199-1208, 2016
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors
AH Jacobs, A Thomas, LW Kracht, H Li, C Dittmar, G Garlip, N Galldiks, ...
Journal of Nuclear Medicine 46 (12), 1948-1958, 2005
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice
MT Heneka, M Ramanathan, AH Jacobs, L Dumitrescu-Ozimek, ...
Journal of Neuroscience 26 (5), 1343-1354, 2006
Advances in neuro-oncology imaging
KJ Langen, N Galldiks, E Hattingen, NJ Shah
Nature Reviews Neurology 13 (5), 279-289, 2017
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18 F] fluoroethyl)-L-tyrosine PET
N Galldiks, V Dunkl, G Stoffels, M Hutterer, M Rapp, M Sabel, ...
European journal of nuclear medicine and molecular imaging 42 (5), 685-695, 2015
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis
N Galldiks, G Stoffels, CP Filss, MD Piroth, M Sabel, MI Ruge, H Herzog, ...
Journal of Nuclear Medicine 53 (9), 1367-1374, 2012
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18 F] Fluoroethyl-L-tyrosine PET in comparison to MRI
N Galldiks, M Rapp, G Stoffels, GR Fink, NJ Shah, HH Coenen, M Sabel, ...
European journal of nuclear medicine and molecular imaging 40 (1), 22-33, 2013
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma
M Rapp, A Heinzel, N Galldiks, G Stoffels, J Felsberg, C Ewelt, M Sabel, ...
Journal of nuclear medicine 54 (2), 229-235, 2013
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a …
U Herrlinger, T Tzaridis, F Mack, JP Steinbach, U Schlegel, M Sabel, ...
The lancet 393 (10172), 678-688, 2019
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI
N Galldiks, KJ Langen, R Holy, M Pinkawa, G Stoffels, KW Nolte, ...
Journal of Nuclear Medicine 53 (7), 1048-1057, 2012
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
N Galldiks, G Stoffels, C Filss, M Rapp, T Blau, C Tscherpel, G Ceccon, ...
Neuro-oncology 17 (9), 1293-1300, 2015
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ...
Neuro-oncology 18 (11), 1529-1537, 2016
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …
I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ...
European journal of nuclear medicine and molecular imaging 46 (3), 540-557, 2019
Use of 11 C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
N Galldiks, LW Kracht, L Burghaus, A Thomas, AH Jacobs, WD Heiss, ...
European journal of nuclear medicine and molecular imaging 33 (5), 516-524, 2006
PET-based molecular imaging in neuroscience
AH Jacobs, H Li, A Winkeler, R Hilker, C Knoess, A Rueger, N Galldiks, ...
European journal of nuclear medicine and molecular imaging 30 (7), 1051-1065, 2003
From the clinician's point of view-What is the status quo of positron emission tomography in patients with brain tumors?
N Galldiks, KJ Langen, WB Pope
Neuro-oncology 17 (11), 1434-1444, 2015
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma
N Galldiks, G Stoffels, MI Ruge, M Rapp, M Sabel, G Reifenberger, ...
Journal of Nuclear Medicine 54 (12), 2046-2054, 2013
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors
CP Filss, N Galldiks, G Stoffels, M Sabel, HJ Wittsack, B Turowski, ...
Journal of nuclear medicine 55 (4), 540-545, 2014
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas
MD Piroth, M Pinkawa, R Holy, J Klotz, S Schaar, G Stoffels, N Galldiks, ...
Strahlentherapie und Onkologie 188 (4), 334-339, 2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20